BLISS GVS PHARMA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 24/10/2024 inter alia to consider and approve Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and half yearly ended September 30 2024 Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and half yearly ended September 30 2024